Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
Status:
Completed
Trial end date:
2021-03-12
Target enrollment:
Participant gender:
Summary
This clinical trial studies steady state blood volume maps using ferumoxytol
non-stoichiometric magnetite magnetic resonance (MRI) in imaging patients with glioblastoma.
MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used
to create detailed pictures of areas inside the body. Contrast agents, such as ferumoxytol
non-stoichiometric magnetite, may enhance these pictures and increase visibility of tumor
cells and the blood vessels in and around the tumors.
Phase:
N/A
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
National Cancer Institute (NCI) Oregon Health and Science University